45 results on '"Waldstreicher, Joanne"'
Search Results
2. Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank
3. Drugs of unproven benefit for COVID-19: a pharma perspective on ethical allocation of available therapies
4. Designing, Conducting, Monitoring, and Analyzing Data from Pragmatic Randomized Clinical Trials: Proceedings from a Multi-stakeholder Think Tank Meeting
5. Technology-Enabled Clinical Trials
6. Individual Patient-Level Data Sharing for Continuous Learning: A Strategy for Trial Data Sharing
7. A Pilot Experiment in Responding to Individual Patient Requests for Compassionate Use of an Unapproved Drug: The Compassionate Use Advisory Committee (CompAC)
8. Overview and experience of the YODA Project with clinical trial data sharing after 5 years
9. Managing Conflicts of Interest in Industry-Sponsored Clinical Research
10. Data Acquisition, Curation, and Use for a Continuously Learning Health System
11. Compassionate Use: A Modest Proposal
12. Compassionate Use: A Modest Proposal
13. The need for even further progress with clinical trial data sharing efforts: patients are waiting
14. Bumps and bridges on the road to responsible sharing of clinical trial data
15. Globalized Pediatric Research
16. A systemic type i 5 α-reductase inhibitor is ineffective in the treatment of acne vulgaris
17. Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia
18. Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia
19. Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia
20. Storage (Irritative) and Voiding (Obstructive) Symptoms as Predictors of Benign Prostatic Hyperplasia Progression and Related Outcomes
21. Lowering Low Density Lipoprotein Cholesterol with Simvastatin, a Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitor, Does Not Affect Luteal Function in Premenopausal Women
22. The Long-Term Effect Of Specific Type II 5??-Reductase Inhibition With Finasteride on Bone Mineral Density in Men: Results of a 4-Year Placebo Controlled Trial
23. Lowering LDL cholesterol with simvastatin, an HMG-CoA reductase inhibitor, does not affect luteal function in women
24. Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia
25. Androgen antagonists: Potential role in prostate cancer prevention
26. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia
27. Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride
28. SERUM PROSTATE SPECIFIC ANTIGEN IS A STRONG PREDICTOR OF FUTURE PROSTATE GROWTH IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
29. Urinary Retention in Patients with BPH Treated with Finasteride or Placebo over 4 Years
30. Measuring Reversal of Hair Miniaturization in Androgenetic Alopecia by Follicular Counts in Horizontal Sections of Serial Scalp Biopsies: Results of Finasteride 1mg Treatment of Men and Postmenopausal Women
31. Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia
32. Patient-Perceived Importance of Negative Effects of Androgenetic Alopecia in Women
33. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo
34. Finasteride in the treatment of men with frontal male pattern hair loss
35. RELATIONSHIPS BETWEEN BASELINE SERUM PSA AND PSA CHANGES, AND PROSTATE VOLUME AND VOLUME CHANGES OVER FOUR YEARS IN PATIENTS ON PLACEBO AND FINASTERIDE
36. Filling vs. Voiding Symptoms as Predictors of Benign Prostatic Hyperplasia-Related Outcomes
37. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia
38. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia
39. Biologic Variability of Prostate-Specific Antigen and its Usefulness as a Marker for Prostate Cancer: Effects of Finasteride
40. The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia
41. Reply
42. Biologic variability of prostate-specific antigen and its usefulness as a marker for prostate cancer: Effects of finasteride
43. A multirater validation study to assess the reliability of acne lesion counting
44. ANOREXIA NERVOSA PRESENTING AS MORBID EXERCISING
45. Hyperfunction of the Hypothalamic-Pituitary Axis in Women with Polycystic Ovarian Disease: Indirect Evidence for Partial Gonadotroph Desensitization*
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.